563 U.S. 27 (2011), 09-1156, Matrixx Initiatives, Inc. v. Siracusano
Linked as:
Extract
563 U.S. 27 (2011), 09-1156, Matrixx Initiatives, Inc. v. Siracusano
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not described in section 201.56(b)(1)
- Code of Federal Regulations - Postmarketing reporting of adverse drug experiences
- Federal Cases - Siracusano v. Matrixx Initiatives, Inc.
- Federal Cases - Tsc Industries, Inc v. Northway, Inc
- Federal Cases - Best v. Lowe's Home Centers, Inc.